James Samuel Shannon is Director at Horizon Therapeutics Public Ltd Co (HZNP). They have made 5 open-market trades across 2 companies since 2019, most recently 2026-03-26.
CIK 0001485417
2 open-market purchases totalling $92K since 2025, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HZNP | 33,156 | $3.9M |
| MNKD | 64,635 | $197K |
| XLO | 10,000 | $88K |
| Total | $4.1M |
Shares reported on the most recent Form 4, priced at the 2026-03-30 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XLO | BUY | 2026-03-26 | 2026-03-30 | $8.79 | $44K | +2.2% | -3.1% | +12.6% |
| XLO | BUY | 2025-06-16 | 2025-06-18 | $0.69 | $48K | -1.0% | +3.2% | +9.4% |
| HZNP | SELL | 2021-03-01 | 2021-03-03 | $91.30 | $1.3M | +2.6% | +0.7% | -0.1% |
| HZNP | SELL | 2019-09-12 | 2019-09-13 | $26.44 | $661K | +3.5% | +3.8% | +25.0% |
| HZNP | SELL | 2019-09-12 | 2019-09-13 | $26.59 | $412K | +3.5% | +3.8% | +25.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.